SCHEMBL29133732

SCHEMBL29133732

CCC1(Nc2ncnc3ccc(-c4cnc(OC)c(OC)c4)cc23)C=CC=CC1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 7/20 0.52
▸ EGFR P00533 2/20 0.52
▸ IRAK4 Q9NWZ3 3/20 0.45
▸ PIK3CD O00329 2/20 0.43
▸ PIK3CB P42338 2/20 0.43
▸ PIK3CG P48736 2/20 0.43
▸ RAF1 P04049 9/20 0.42
▸ BRAF P15056 9/20 0.42
▸ KDM4E B2RXH2 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133728 0.83 IRAK4 (0.48) EGFRIRAK4USP2CYP1A2CYP3A4
SCHEMBL29133720 0.82 MELK (0.40) PIK3CAEGFRPIK3CDPIK3CBPIK3CG
SCHEMBL29133716 0.82 IRAK4 (0.39) EGFRIRAK4USP2CYP1A2CYP3A4
SCHEMBL29133742 0.81 IRAK4 (0.35) PIK3CAIRAK4PIK3CDRAF1BRAF
SCHEMBL29133774 0.81 IRAK4 (0.47) PIK3CAEGFRIRAK4RAF1LMNA
SCHEMBL29133704 0.80 IRAK4 (0.54) PIK3CAEGFRIRAK4PIK3CDPIK3CB
SCHEMBL29133745 0.77 HTT (0.50) IRAK4KDM4ELMNACYP1A2CYP3A4
SCHEMBL29133739 0.77 HTT (0.50) IRAK4KDM4ELMNACYP1A2CYP3A4
SCHEMBL29133752 0.77 HTT (0.36) EGFRIRAK4LMNA
SCHEMBL29133735 0.77 HTT (0.36) EGFRIRAK4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback